The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI

Histopathologically identified prostate cancer lesions were sparse in 37 % of cases. Sparse cancers were entirely low grade in TZ and predominantly low-grade in PZ and generally small, thus likely posing lower risk for spread and progression than dense lesions. Sparse lesions were not distinguishable from dense lesions on mpMRI, but could be distinguished from benign tissues.

Authors

Institutions

Publication Details

Journal
Magnetic Resonance Imaging
Published
2024-09-10
DOI
https://doi.org/10.1016/j.mri.2024.110233
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI

John V. Kurhanewicz, Jeffry Simko, Peter R. Carroll, Olga Starobinets et al.
1 links
Magnetic Resonance Imaging
Prostate Cancer Diagnosis and Treatment
article

The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI

John V. Kurhanewicz, Jeffry Simko, Peter R. Carroll, Olga Starobinets, Matthew Gibbons, Susan M. Noworolski
article en

Abstract

Histopathologically identified prostate cancer lesions were sparse in 37 % of cases. Sparse cancers were entirely low grade in TZ and predominantly low-grade in PZ and generally small, thus likely posing lower risk for spread and progression than dense lesions. Sparse lesions were not distinguishable from dense lesions on mpMRI, but could be distinguished from benign tissues.

Magnetic Resonance ImagingVol. 114
University of California, San Francisco (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), University of California, Berkeley (US)
National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 73%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.